 |
 |
Definition: scale employed in the prognostication of non-Hodgkin lymphoma; based on presence or absence of five components including older age, advanced stage, LDH elevation, more than one extralymphatic site of involvement, and poor performance status of the patient.
Examples: glitazone, GI cocktail, etc.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2013 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
